Barry E. Greene, President & COO at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 24,058 shares at $25.00 ($601K) on 2013-03-14, disclosed to the SEC on 2013-03-18.
Scheduled sale ($601k) by President & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |